<DOC>
	<DOCNO>NCT01631292</DOCNO>
	<brief_summary>In study , provide supplemental vitamin D postmenopausal overweight/obese woman , hypothesize affect areal BMD , alter bone compartment ( trabecular cortical bone ) . In addition , high vitamin D intake increase serum 25OHD suppress serum PTH bone turnover weight reduction . Secondary outcome include influence vitamin D weight loss marker insulin resistance cognitive test attention , learning , memory .</brief_summary>
	<brief_title>Vitamin D Supplementation Obesity Weight Loss ( 3DD Study )</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Body mass index 2540 kg/m2 , Postmenopausal , Age 5072 year . Women take medication know influence Ca bone metabolism , evidence disease know influence Ca metabolism ( i.e . metabolic bone disease , hyperparathyroidism , untreated thyroid disease , significant immune , hepatic , renal disease , kidney stone last 5 yrs. , significant cardiac disease , active malignancy cancer therapy within past year ) eligible .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>